{"id":"https://openalex.org/W2073009553","doi":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","title":"Induction of P\u2010glycoprotein and Bcrp at the rat blood\u2013brain barrier following a subchronic morphine treatment is mediated through NMDA / COX \u20102 activation","display_name":"Induction of P\u2010glycoprotein and Bcrp at the rat blood\u2013brain barrier following a subchronic morphine treatment is mediated through NMDA / COX \u20102 activation","alternate_titles":[],"publication_year":2012,"publication_date":"2012-09-03","ids":{"openalex":"https://openalex.org/W2073009553","doi":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","mag":"2073009553","pmid":"https://pubmed.ncbi.nlm.nih.gov/22845665"},"language":"en","primary_location":{"id":"doi:10.1111/j.1471-4159.2012.07890.x","doi":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2012.07890.x","source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2073009553"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2012.07890.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014392909","display_name":"Salah Yousif","orcid":"https://orcid.org/0000-0003-0834-3465","observed_orcids":["https://orcid.org/0000-0003-0834-3465"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Salah Yousif","raw_affiliation_strings":["CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","INSERM, U705 Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4387156284"]},{"raw_affiliation_string":"INSERM, U705 Paris France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064846451","display_name":"Catarina Chaves","orcid":"https://orcid.org/0000-0002-7108-4702","observed_orcids":["https://orcid.org/0000-0002-7108-4702"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catarina Chaves","raw_affiliation_strings":["CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","INSERM, U705 Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4387156284"]},{"raw_affiliation_string":"INSERM, U705 Paris France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078935566","display_name":"Sophie Potin","orcid":"https://orcid.org/0000-0002-7881-3138","observed_orcids":["https://orcid.org/0000-0002-7881-3138"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sophie Potin","raw_affiliation_strings":["CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","INSERM, U705 Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4387156284"]},{"raw_affiliation_string":"INSERM, U705 Paris France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082802774","display_name":"Isabelle Margaill","orcid":"https://orcid.org/0000-0002-7941-6644","observed_orcids":["https://orcid.org/0000-0002-7941-6644"]},"institutions":[{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4405258415","display_name":"Pharmacologie de la circulation c\u00e9r\u00e9brale","ror":"https://ror.org/00m87vz37","country_code":"FR","type":"facility","lineage":["https://openalex.org/I204730241","https://openalex.org/I4405258415"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isabelle Margaill","raw_affiliation_strings":["EA 4475, Pharmacologie de la Circulation C\u00e9r\u00e9brale, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EA 4475, Pharmacologie de la Circulation C\u00e9r\u00e9brale, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","institution_ids":["https://openalex.org/I4387156284","https://openalex.org/I4405258415"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108778722","display_name":"Jean\u2010Michel Scherrmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean\u2010Michel Scherrmann","raw_affiliation_strings":["CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","INSERM, U705 Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4387156284"]},{"raw_affiliation_string":"INSERM, U705 Paris France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082432867","display_name":"Xavier Decl\u00e8ves","orcid":"https://orcid.org/0000-0002-9526-2294","observed_orcids":["https://orcid.org/0000-0002-9526-2294"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Xavier Decl\u00e8ves","raw_affiliation_strings":["CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","INSERM, U705 Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, UMR 8206, Neuropsychopharmacologie des addictions, Facult\u00e9 des Sciences Pharmaceutiques et Biologiques Universit\u00e9 Paris Descartes Paris France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4387156284"]},{"raw_affiliation_string":"INSERM, U705 Paris France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5082432867"],"corresponding_institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4387156284"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":2.6083,"has_fulltext":true,"cited_by_count":47,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89786406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"123","issue":"4","first_page":"491","last_page":"503"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9279999732971191},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.9279999732971191},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9269999861717224},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9869999885559082},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.5979999899864197},{"id":"https://openalex.org/keywords/morphine-withdrawal","display_name":"morphine withdrawal","score":0.8550000190734863},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.8529999852180481},{"id":"https://openalex.org/keywords/prostaglandin-e2-receptor","display_name":"prostaglandin E2 receptor","score":0.9039999842643738},{"id":"https://openalex.org/keywords/misoprostol","display_name":"misoprostol","score":0.7900000214576721},{"id":"https://openalex.org/keywords/iloprost","display_name":"iloprost","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cerebral-microvasculature","display_name":"cerebral microvasculature","score":0.7390000224113464},{"id":"https://openalex.org/keywords/hcmec-d3-endothelial-cells","display_name":"hCMEC/D3 endothelial cells","score":0.8100000023841858},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.3140000104904175}],"concepts":[{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.6796923875808716},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6382200121879578},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.5927151441574097},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5761232972145081},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.5751716494560242},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5088603496551514},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.3042309880256653},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29824262857437134},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.20186838507652283},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16274133324623108},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11379322409629822},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000070997","descriptor_name":"ATP Binding Cassette Transporter, Subfamily G, Member 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077239","descriptor_name":"Meloxicam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001808","descriptor_name":"Blood Vessels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000033","qualifier_name":"anatomy & histology","is_major_topic":false},{"descriptor_ui":"D002461","descriptor_name":"Cell Line, Transformed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013843","descriptor_name":"Thiazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016202","descriptor_name":"N-Methylaspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016285","descriptor_name":"Iloprost","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016595","descriptor_name":"Misoprostol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018435","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018435","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1471-4159.2012.07890.x","doi":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2012.07890.x","source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:22845665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22845665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1471-4159.2012.07890.x","doi":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2012.07890.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2012.07890.x","source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320334779","display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","ror":"https://ror.org/00snfqn58"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2073009553.pdf","grobid_xml":"https://content.openalex.org/works/W2073009553.grobid-xml"},"referenced_works_count":60,"referenced_works":["https://openalex.org/W98155210","https://openalex.org/W189644703","https://openalex.org/W1518096905","https://openalex.org/W1569290580","https://openalex.org/W1577858425","https://openalex.org/W1974369773","https://openalex.org/W1981625417","https://openalex.org/W1982542571","https://openalex.org/W1988357026","https://openalex.org/W1990474450","https://openalex.org/W1993184426","https://openalex.org/W1995267211","https://openalex.org/W1999190513","https://openalex.org/W2011800934","https://openalex.org/W2014012004","https://openalex.org/W2019695588","https://openalex.org/W2020358268","https://openalex.org/W2021275669","https://openalex.org/W2022217072","https://openalex.org/W2026262374","https://openalex.org/W2030571587","https://openalex.org/W2036299072","https://openalex.org/W2039939316","https://openalex.org/W2041436541","https://openalex.org/W2043527756","https://openalex.org/W2043773337","https://openalex.org/W2047093625","https://openalex.org/W2051372812","https://openalex.org/W2052940138","https://openalex.org/W2055650738","https://openalex.org/W2063136699","https://openalex.org/W2066038116","https://openalex.org/W2069228549","https://openalex.org/W2072614072","https://openalex.org/W2072943045","https://openalex.org/W2080822069","https://openalex.org/W2081577644","https://openalex.org/W2082936971","https://openalex.org/W2087402693","https://openalex.org/W2090945850","https://openalex.org/W2092825895","https://openalex.org/W2094728055","https://openalex.org/W2095481560","https://openalex.org/W2097088407","https://openalex.org/W2103800437","https://openalex.org/W2104386693","https://openalex.org/W2107798346","https://openalex.org/W2108486409","https://openalex.org/W2110256990","https://openalex.org/W2110606022","https://openalex.org/W2129242841","https://openalex.org/W2136564762","https://openalex.org/W2139959086","https://openalex.org/W2143154387","https://openalex.org/W2144497954","https://openalex.org/W2156900818","https://openalex.org/W2171495449","https://openalex.org/W2172258081","https://openalex.org/W2271894037","https://openalex.org/W2330070213"],"related_works":["https://openalex.org/W2039939316","https://openalex.org/W2120175098","https://openalex.org/W4392396531","https://openalex.org/W3031182479","https://openalex.org/W3029891486","https://openalex.org/W2412607878","https://openalex.org/W578651234","https://openalex.org/W1990474450","https://openalex.org/W2387242161","https://openalex.org/W2067956029"],"abstract_inverted_index":{"Subchronic":[0],"morphine":[1,34,42,137,157,190,219,236],"treatment":[2,191],"induces":[3],"P-glycoprotein":[4],"(P-gp)":[5],"up-regulation":[6],"at":[7,27,121,141],"the":[8,14,28,72,112,165,168,229,243],"blood-brain":[9,30],"barrier.":[10],"This":[11,144],"study":[12],"investigates":[13],"rate":[15],"and":[16,21,58,68,77,82,86,93,100,117,125,138,170,184,195,200,212,225],"extent":[17],"to":[18],"which":[19],"P-gp":[20,81,124,194,224],"breast":[22],"cancer-resistance":[23],"protein":[24,78,127],"(Bcrp)":[25],"increase":[26],"rat":[29],"barrier":[31],"following":[32],"subchronic":[33],"treatment.":[35],"Rats":[36],"were":[37,60,89,103],"given":[38,188],"increasing":[39],"doses":[40],"of":[41,80,98,159,167,205],"(10-40":[43],"mg/kg)":[44],"or":[45],"saline":[46],"i.p.":[47],"twice":[48],"daily":[49],"for":[50],"5":[51],"days.":[52],"The":[53,75,96],"brain":[54,130,177,230],"cortex":[55],"large":[56,150],"vessels":[57,151],"microvessels":[59,131],"then":[61],"mechanical":[62],"isolated":[63],"6,":[64],"9,":[65],"12,":[66],"24,":[67],"36":[69],"h":[70,108,135],"after":[71,189],"last":[73],"injection.":[74],"gene":[76],"expression":[79,128,227],"Bcrp":[83,101,118,126,196,226],"in":[84,129,149,153,173,179,216],"morphine-treated":[85],"control":[87],"rats":[88],"compared":[90],"by":[91,228,241],"qRT-PCR":[92],"western":[94],"blotting.":[95],"levels":[97,215],"Mdr1a":[99,113],"mRNAs":[102],"not":[104,163,221],"significantly":[105],"modified":[106],"6":[107,134],"post":[109,136],"morphine,":[110],"but":[111,232],"mRNA":[114,119,214],"increased":[115,139],"1.4-fold":[116],"2.4-fold":[120],"24":[122,142],"h.":[123,143],"was":[132,146],"unchanged":[133],"1.5-fold":[140],"effect":[145],"more":[147],"pronounced":[148],"than":[152],"microvessels.":[154],"However,":[155],"extracellular":[156],"concentrations":[158],"0.01-10":[160],"\u03bcM":[161],"did":[162],"modify":[164],"expressions":[166],"MDR1":[169,211],"BCRP":[171,213],"genes":[172],"hCMEC/D3":[174],"human":[175],"endothelial":[176],"cells":[178],"vitro.":[180],"MK-801":[181],"(NMDA":[182],"antagonist)":[183],"meloxicam":[185],"(cyclo-oxygenase-2":[186],"inhibitor)":[187],"completely":[192],"blocked":[193],"up-regulation.":[197],"Interestingly,":[198],"misoprostol":[199],"iloprost,":[201],"two":[202],"well-known":[203],"agonists":[204],"prostaglandin":[206],"E2":[207],"receptors":[208],"induced":[209],"both":[210],"hCMEC/D3.":[217],"Thus,":[218],"does":[220],"directly":[222],"stimulate":[223],"endothelium,":[231],"glutamate":[233],"released":[234],"during":[235],"withdrawal":[237],"may":[238],"do":[239],"so":[240],"activating":[242],"NMDA/cyclo-oxygenase-2":[244],"cascade.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2073009553","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
